Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harris

Showing results (341-350 of 430) with videos related to

Pageof 43
Sort By:
BJU International|April 13, 2018
Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)Alistair F Ray, John Powell, Mark J Speakman, et al.
The Journal of General Virology|December 19, 2025
Identification and characterization of candidate inhibitors of the SARS-CoV-2 nsp14 3'-5' exoribonucleaseVictoria Easton, Martin J McPhillie, Igor Andrade Santos, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channelToshana L Foster, Mark Verow, Ann L Wozniak, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 24, 2025
General practice incentives: a review of the international literatureMark Harris, Joel Rhee, Margo Barr, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 19, 2026
Antiviral potential of galactose-binding lectin from Vatairea macrocarpa seeds against SARS-CoV-2Victória Riquena Grosche, Igor Andrade Santos, Robinson Sabino-Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinaseJamel Mankouri, Philip R Tedbury, Sarah Gretton, et al.
Journal of Virology|February 24, 2012
High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitorsLaura F Wetherill, Kristopher K Holmes, Mark Verow, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 12, 2026
Lisboaeflavanonol A: a novel Amazonian molecule as a potent antiviral compound with activity against SARS-CoV-2Victória Riquena Grosche, Igor Andrade Santos, João Pedro Lima Sampaio, et al.
BMJ Open|July 29, 2019
Improving access to primary healthcare for vulnerable populations in Australia and Canada: protocol for a mixed-method evaluation of six complex interventionsGrant Russell, Marina Kunin, Mark Harris, et al.
Psychology, Health & Medicine|September 21, 2019
The influence of personality on trajectories of distress, health and functioning in mild-to-moderately depressed adults with type 2 diabetesSamineh Sanatkar, Peter Baldwin, Janine Clarke, et al.
Pageof 43

Showing results (341-350 of 430) with videos related to

Sort By:
Pageof 43
BJU International|April 13, 2018
Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)Alistair F Ray, John Powell, Mark J Speakman, et al.
The Journal of General Virology|December 19, 2025
Identification and characterization of candidate inhibitors of the SARS-CoV-2 nsp14 3'-5' exoribonucleaseVictoria Easton, Martin J McPhillie, Igor Andrade Santos, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channelToshana L Foster, Mark Verow, Ann L Wozniak, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 24, 2025
General practice incentives: a review of the international literatureMark Harris, Joel Rhee, Margo Barr, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 19, 2026
Antiviral potential of galactose-binding lectin from Vatairea macrocarpa seeds against SARS-CoV-2Victória Riquena Grosche, Igor Andrade Santos, Robinson Sabino-Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinaseJamel Mankouri, Philip R Tedbury, Sarah Gretton, et al.
Journal of Virology|February 24, 2012
High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitorsLaura F Wetherill, Kristopher K Holmes, Mark Verow, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 12, 2026
Lisboaeflavanonol A: a novel Amazonian molecule as a potent antiviral compound with activity against SARS-CoV-2Victória Riquena Grosche, Igor Andrade Santos, João Pedro Lima Sampaio, et al.
BMJ Open|July 29, 2019
Improving access to primary healthcare for vulnerable populations in Australia and Canada: protocol for a mixed-method evaluation of six complex interventionsGrant Russell, Marina Kunin, Mark Harris, et al.
Psychology, Health & Medicine|September 21, 2019
The influence of personality on trajectories of distress, health and functioning in mild-to-moderately depressed adults with type 2 diabetesSamineh Sanatkar, Peter Baldwin, Janine Clarke, et al.
Pageof 43